TH-A-BRF-03: Evaluation of Synthetic CTs Generated Using MR-SIM Data




To describe and evaluate a novel algorithm for generating synthetic CT images from MR-SIM data for dose calculations in MR-only treatment planning.


A voxel-based weighted summation method was implemented to generate synthetic CT (synCT) images. MR data were acquired using Philips 1.0T Panorama high-field open MR-SIM. Retrospective patient data from seven prostate patients and one brain patient (three lesions) enrolled in an IRB-approved study were used. 3D T1-weighted fast field echo and 3D T2-weighted turbo spin echo sequences were utilized for all patients. A 3D balanced turbo field echo sequence using spectral presaturation with inversion recovery was acquired for prostate patients, but 3D ultra-short echo time (UTE)-DIXON was instead acquired for the brain patient to amplify bone signal for semi-automatic bone segmentation. Weight optimization was performed using a training subset of patients. HU value differences between planning CT and synCTs were analyzed using mean absolute error (MAE). Original patient CT-based treatment plans were mapped onto synCTs, dose was recalculated using original leaf motion and MU values, and DRRs were generated. Dosevolume metrics and gamma analysis were used for dosimetric evaluation.


Average whole-body MAE of synCTs across all patients was 75+12 HU. In prostate cancer patients, average HU difference between planning and synCTs was 0.9±1.0% for soft tissue structures and 4.3±2.5% for bony structures. DRRs were generated from synCTs and qualitatively showed good geometric agreement with planning CT-generated DRRs. D99, mean dose, and maximum dose to CTV calculated using the synCT remained within 1.2% of planning CT-based dose calculations. All gamma analysis evaluated at 2%/2mm dose difference/distance to agreement) pass rates were greater than 95% with an average of 99.9±0.1% for prostate patients and 98.4±2.2% for three brain lesions.


SynCTs were generated with clinically acceptable accuracy comparable to planning CTs, enabling dose computations for MR-only simulation.

Research supported in part by a grant from Philips HealthCare (Best, Netherlands).